Literature DB >> 29761722

A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Long-term (12-month) follow-up at one site.

Cinda L Hugos1, Michelle H Cameron1, Zunqiu Chen2, Yiyi Chen2, Dennis Bourdette1.   

Abstract

BACKGROUND: A four-site RCT of Fatigue: Take Control (FTC), a multicomponent group program, found no significant differences from a control program, MS: Take Control (MSTC), in fatigue on the Modified Fatigue Impact Scale (MFIS) through 6 months.
OBJECTIVE: Assess FTC for a delayed effect on fatigue.
METHODS: Of 78 subjects at one site, 74 randomized to FTC or MSTC completed the MFIS at 12 months.
RESULTS: Compared to baseline, FTC produced greater improvements in MFIS scores than MSTC (FTC -8.9 (confidence interval (CI): 32.2, 45), MSTC -2.5 (CI 39.6, 47.7), p = 0.03) at 12 months.
CONCLUSION: The delayed effect of FTC on fatigue suggests the need for longer follow-up when assessing interventions for fatigue.

Entities:  

Keywords:  Multiple sclerosis; clinical trial; fatigue; rehabilitation; self-care; symptom management

Mesh:

Year:  2018        PMID: 29761722     DOI: 10.1177/1352458518775920

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  3 in total

1.  A multisite randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Very long term (5-6 year) follow-up at one site.

Authors:  Julia Norton; Sandra Joos; Michelle H Cameron; Cinda L Hugos
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-11-25

2.  MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial.

Authors:  Cinda L Hugos; Michelle H Cameron
Journal:  BMC Neurol       Date:  2020-10-07       Impact factor: 2.474

3.  Which exercise and behavioural interventions show most promise for treating fatigue in multiple sclerosis? A network meta-analysis.

Authors:  Anthony M Harrison; Reza Safari; Tom Mercer; Federica Picariello; Marietta L van der Linden; Claire White; Rona Moss-Morris; Sam Norton
Journal:  Mult Scler       Date:  2021-04-20       Impact factor: 6.312

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.